ML-9, a myosin light chain kinase inhibitor, reduces intracellular Ca 2+ concentration in guinea pig trachealis

European Journal of Pharmacology

Volumn 486, Issue 3, 2004, Pages 325-333

  Ito, Satoru ^a   Kume, Hiroaki ^a   Honjo, Haruo ^b   Kodama, Itsuo ^b   Katoh, Hideki ^c   Hayashi, Hideharu ^c   Shimokata, Kaoru ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Ca2+ channel; Ca2+ entry, capacitative; Fura 2; Myosin light chain kinase; Smooth muscle, airway

Indexed keywords

1 (5 CHLORO 1 NAPHTHALENESULFONYL)HEXAHYDRO 1H 1,4 DIAZEPINE; 1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL STIMULATING AGENT; CALCIUM ION; METHACHOLINE; MYOSIN LIGHT CHAIN KINASE INHIBITOR; POTASSIUM ION; THAPSIGARGIN; WORTMANNIN;

ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG MECHANISM; GUINEA PIG; INHIBITION KINETICS; MEMBRANE PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION; TRACHEA;

EID: 1242292230     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.01.013     Document Type: Article

References (41)

1. Ammit A.J., Armour C.L., Black J.L. Smooth-muscle myosin light-chain kinase content is increased in human sensitized airways. Am. J. Respir. Crit. Care Med. 161:2000;257-263.
2. 2+ movements and contractions in vascular smooth muscle. Eur. J. Pharmacol. 294:1995;693-701.
3. Bain J., McLauchlan H., Elliott M., Cohen P. The specificities of protein kinase inhibitors: an update. Biochem. J. 371:2003;199-204.
4. 2+ signaling requirements. Biochem. J. 337:1999;153-169.
5. 2+], electrical activity and force in phasic smooth muscle. Pflügers Arch.-Eur. J. Physiol. 436:1998;801-803.
6. Davis S.P., Reddy H., Caivano M., Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351:2000;95-105.
7. 2+ entry and tyrosine kinase activation in canine pulmonary arterial smooth muscle cells. Am. J. Physiol. 278:2000;L118-L130.
8. Ethier M.F., Madison J.M. LY294002, but not wortmannin, increases intracellular calcium and inhibits calcium transients in bovine and human airway smooth muscle cells. Cell Calcium. 32:2002;31-38.
9. Fernandes D.J., Mitchell R.W., Lakser O., Dowell M., Stewart A.G., Solway J. Invited Review: do inflammatory mediators influence the contribution of airway smooth muscle contraction to airway hyperresponsiveness in asthma? J. Appl. Physiol. 95:2003;844-853.
10. Gallagher P.J., Herring B.P., Stull J.T. Myosin light chain kinases. J. Muscle Res. Cell Motil. 18:1997;1-16.
11. Gerthoffer W.T. Regulation of the contractile element of airway smooth muscle. Am. J. Physiol. 261:1991;L15-L28.
12. Ishikawa T., Chijiwa T., Hagiwara M., Mamiya S., Saitoh M., Hidaka H. ML-9 inhibits the vascular contraction via the inhibition of myosin light chain phosphorylation. Mol. Pharmacol. 33:1988;598-603.
13. 2+ mobilization by MCh in tracheal smooth muscle. Am. J. Physiol. 280:2001;L1218-L1224.
14. 2+ entry by Rho-kinase in tracheal smooth muscle. Am. J. Respir. Cell Mol. Biol. 26:2002;491-498.
15. Itoh T., Ikebe M., Kargacin G.J., Hartshorne D.J., Kemp B.E., Fay F.S. Effects of modulators of myosin light-chain kinase activity in single smooth muscle cells. Nature. 338:1989;164-167.
16. Kai T., Yoshimura H., Jones K.A., Warner D.O. Relationship between force and regulatory myosin light chain phosphorylation in airway smooth muscle. Am. J. Physiol. 279:2000;L52-L58.
17. Kamm K.E., Stull J.T. Dedicated myosin light chain kinases with diverse cellular functions. J. Biol. Chem. 276:2001;4527-4530.
18. Karaki H., Ozaki H., Hori M., Mitsui-Saito M., Amano K., Harada K., Miyamoto S., Nakazawa H., Won K.J., Sato K. Calcium movements, distribution, and function in smooth muscle. Pharmacol. Rev. 49:1997;157-230.
19. Kimura K., Ito M., Amano M., Chihara K., Fukata Y., Nakafuku M., Yamamori B., Feng J., Nakano T., Okawa K., Iwamatsu A., Kaibuchi K. Regulation of myosin phosphatase by Rho and Rho-associated protein kinase (Rho-kinase). Science. 273:1996;245-248.
20. Konishi M., Olson A., Hollingworth S., Baylor S.M. Myoplasmic binding of fura-2 investigated by steady-state fluorescence and absorbance measurements. Biophys. J. 54:1988;1089-1104.
21. Ca channels in muscarinic and β-adrenergic regulation of airway smooth muscle. Am. J. Physiol. 268:1995;L221-L229.
22. 2+ sensitization in tracheal smooth muscle. Am. J. Respir. Cell Mol. Biol. 25:2001;291-298.
23. 2+ entry in in situ endothelial cells of the porcine aortic valve and the endothelium- dependent relaxation in the porcine coronary artery. Br. J. Pharmacol. 131:2000;115-123.
24. Li L., Kankaanranta H., Vaali K., Paakkari I., Vapaatalo H. Econazole, miconazole and SK&F 96365 inhibit depolarization-induced and receptor-operated contraction of guinea-pig isolated trachea in vitro. Eur. J. Pharmacol. 331:1997;221-225.
25. Longbottom E.R., Lukas M.J.M., Kupittayanant S., Badrick E., Shimigol T., Wray S. The effects of inhibiting myosin light chain kinase on contraction and calcium signaling in human and rat myometrium. Pflügers Arch.-Eur. J. Physiol. 440:2000;315-321.
26. Ma X., Chen Z., Kong H., Wang Y., Unruh H., Stephens N.L., Laviolette M. Changes in biophysical and biochemical properties of single bronchial smooth muscle cells from asthmatic subjects. Am. J. Physiol. 283:2002;L1181-L1189.
27. Merritt J.E., Armstrong W.P., Benham C.D., Hallam T.J., Jacob R., Jaxa-Chamiec A., Leigh B.K., McCarthy S.A., Moores K.E., Rink T.J. SK&F 96365, a novel inhibitor of receptor-mediated calcium entry. Biochem. J. 271:1990;515-528.
28. Murray R.K., Kotlikoff M.I. Receptor-activated calcium influx in human airway smooth muscle cells. J. Physiol. (Lond.). 436:1991;123-144.
29. Nakanishi S., Kakita S., Takahashi I., Kawahara K., Tsukuda E., Sano T., Yamada K., Yoshida M., Kase H., Matsuda Y., Hashimoto Y., Nonomura Y. Wortmannin, a microbial product inhibitor of myosin light chain kinase. J. Biol. Chem. 267:1992;2157-2163.
30. Norwood N., Moore T.M., Dean D.A., Bhattacharjee R., Li M., Stevens T. Store-operated calcium entry and increased endothelial cell permeability. Am. J. Physiol. 279:2000;L815-L824.
31. Ozaki H., Sato K., Satoh T., Karaki H. Simultaneous recordings of calcium signals and mechanical activity using fluorescent dye fura 2 in isolated strips of vascular smooth muscle. Jpn. J. Pharmacol. 45:1987;429-433.
32. 2+ and contraction induced by various stimulants and relaxants in canine tracheal smooth muscle. Pflügers Arch.-Eur. J. Physiol. 416:1990;351-359.
33. Putney J.W. Jr. Capacitative calcium entry revisited. Cell Calcium. 11:1990;611-624.
34. Saitoh M., Ishikawa T., Matsushima S., Naka M., Hidaka H. Selective inhibition of catalytic activity of smooth muscle myosin light chain kinase. J. Biol. Chem. 262:1987;7796-7801.
35. Somlyo A.P., Somlyo A.V. Signal transduction by G-proteins, Rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J. Physiol. (Lond.). 522:2000;177-185.
36. 2+ levels, myosin light chain phosphorylation and force in vascular smooth muscle. Naunyn- Schmiedeberg's Arch. Pharmacol. 354:1996;120-127.
37. 2+-ATPase. Proc. Natl. Acad. Sci. U. S. A. 87:1990;2466-2470.
38. 2+ influx in endothelial cells. FASEB J. 12:1998;341-348.
39. Watanabe H., Tran Q.K., Takeuchi K., Fukao M., Liu M.Y., Kanno M., Hayashi T., Iguchi A., Seto M., Ohashi K. Myosin light-chain kinase regulates endothelial calcium entry and endothelium-dependent vasodilation. FASEB J. 15:2000;282-284.
40. 2+-dependent contraction in swine carotid artery by myosin kinase inhibitors. Gen. Pharmacol. 32:1999;483-494.
41. Yano H., Nakanishi S., Kimura K., Hanai N., Saitoh Y., Fukui Y., Nonomura Y., Matsuda Y. Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J. Biol. Chem. 268:1993;25846-25856.